Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: Final results and long-term outcome Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Chemoradiotherapy
  • Lymphoma

abstract

  • R-MPV combined with consolidation rdWBRT and cytarabine is associated with high response rates, long-term disease control, and minimal neurotoxicity.

publication date

  • November 2013

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC5569679

Digital Object Identifier (DOI)

  • 10.1200/JCO.2013.50.4910

PubMed ID

  • 24101038

Additional Document Info

start page

  • 3971

end page

  • 9

volume

  • 31

number

  • 31